Gene Symbol | Gene ID | Gene Info |
---|---|---|
EOMES
|
ENSG00000163508.8 | eomesodermin |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_27684776_27684927 | EOMES | 78952 | 0.099753 | -0.82 | 6.3e-03 | Click! |
chr3_27680743_27680984 | EOMES | 82940 | 0.092552 | 0.81 | 7.5e-03 | Click! |
chr3_27944363_27944514 | EOMES | 180232 | 0.032426 | 0.81 | 8.2e-03 | Click! |
chr3_27764573_27764860 | EOMES | 510 | 0.880931 | 0.78 | 1.3e-02 | Click! |
chr3_27685010_27685161 | EOMES | 78718 | 0.100192 | -0.77 | 1.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_99677205_99677461 | 2.04 |
AL109767.1 |
|
51952 |
0.13 |
chrX_128913033_128913442 | 1.58 |
SASH3 |
SAM and SH3 domain containing 3 |
723 |
0.69 |
chr7_50251136_50251506 | 1.30 |
AC020743.2 |
|
68902 |
0.11 |
chr16_75131890_75132275 | 1.21 |
ZNRF1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
6600 |
0.16 |
chr5_176791964_176792115 | 1.20 |
RGS14 |
regulator of G-protein signaling 14 |
1905 |
0.18 |
chr13_24827502_24827881 | 1.19 |
SPATA13-AS1 |
SPATA13 antisense RNA 1 |
886 |
0.52 |
chr17_2696745_2696911 | 1.12 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
2904 |
0.24 |
chr1_226188532_226188755 | 1.08 |
SDE2 |
SDE2 telomere maintenance homolog (S. pombe) |
1611 |
0.34 |
chr5_175960511_175960662 | 1.02 |
RNF44 |
ring finger protein 44 |
2940 |
0.17 |
chr9_139305577_139305763 | 1.02 |
PMPCA |
peptidase (mitochondrial processing) alpha |
557 |
0.41 |
chr2_109649380_109649861 | 1.02 |
EDAR |
ectodysplasin A receptor |
43792 |
0.18 |
chr17_79386597_79386769 | 1.00 |
ENSG00000266392 |
. |
12105 |
0.11 |
chr3_9221587_9221882 | 0.99 |
SRGAP3-AS2 |
SRGAP3 antisense RNA 2 |
12443 |
0.21 |
chr20_62199024_62199397 | 0.99 |
HELZ2 |
helicase with zinc finger 2, transcriptional coactivator |
217 |
0.87 |
chr15_75939798_75939949 | 0.99 |
SNX33 |
sorting nexin 33 |
374 |
0.69 |
chr4_90221268_90221504 | 0.97 |
GPRIN3 |
GPRIN family member 3 |
7775 |
0.31 |
chr19_18810369_18810520 | 0.94 |
CRTC1 |
CREB regulated transcription coactivator 1 |
15956 |
0.14 |
chr3_9211344_9211532 | 0.93 |
SRGAP3-AS2 |
SRGAP3 antisense RNA 2 |
22739 |
0.19 |
chr4_151937156_151937307 | 0.93 |
LRBA |
LPS-responsive vesicle trafficking, beach and anchor containing |
352 |
0.89 |
chr15_68053321_68053501 | 0.92 |
SKOR1 |
SKI family transcriptional corepressor 1 |
58631 |
0.14 |
chr10_126404133_126404651 | 0.92 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
11639 |
0.18 |
chr12_7069437_7069760 | 0.92 |
ENSG00000207713 |
. |
3264 |
0.07 |
chr8_27235111_27235488 | 0.89 |
PTK2B |
protein tyrosine kinase 2 beta |
2869 |
0.31 |
chr16_88761558_88761720 | 0.89 |
RP5-1142A6.5 |
|
1270 |
0.21 |
chr11_441168_441370 | 0.89 |
ENSG00000243562 |
. |
576 |
0.42 |
chr12_117500389_117500917 | 0.88 |
TESC |
tescalcin |
16017 |
0.25 |
chr11_65547712_65547863 | 0.87 |
AP5B1 |
adaptor-related protein complex 5, beta 1 subunit |
486 |
0.64 |
chr17_72736889_72737131 | 0.87 |
RAB37 |
RAB37, member RAS oncogene family |
3639 |
0.12 |
chr2_198164541_198165310 | 0.86 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
2318 |
0.26 |
chr4_6696945_6697157 | 0.86 |
S100P |
S100 calcium binding protein P |
2255 |
0.22 |
chr2_173291489_173291761 | 0.84 |
ITGA6 |
integrin, alpha 6 |
457 |
0.77 |
chr5_443636_443787 | 0.84 |
EXOC3 |
exocyst complex component 3 |
328 |
0.57 |
chr14_89507015_89507229 | 0.83 |
FOXN3 |
forkhead box N3 |
139966 |
0.05 |
chr21_46337383_46337695 | 0.83 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
3231 |
0.13 |
chr1_11800377_11800922 | 0.82 |
AGTRAP |
angiotensin II receptor-associated protein |
4417 |
0.14 |
chr1_160544654_160544962 | 0.82 |
CD84 |
CD84 molecule |
4455 |
0.17 |
chr1_154925948_154926281 | 0.82 |
PBXIP1 |
pre-B-cell leukemia homeobox interacting protein 1 |
2466 |
0.12 |
chr19_11159205_11159728 | 0.82 |
SMARCA4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
10045 |
0.14 |
chr3_16346570_16347098 | 0.81 |
RP11-415F23.2 |
|
9112 |
0.17 |
chr16_27245936_27246162 | 0.81 |
NSMCE1 |
non-SMC element 1 homolog (S. cerevisiae) |
1650 |
0.34 |
chr4_125633047_125633285 | 0.80 |
ANKRD50 |
ankyrin repeat domain 50 |
721 |
0.82 |
chr17_76129423_76129727 | 0.79 |
TMC6 |
transmembrane channel-like 6 |
1087 |
0.35 |
chr2_243027351_243027563 | 0.79 |
RP11-341N2.1 |
|
3151 |
0.26 |
chr1_170633574_170633876 | 0.79 |
PRRX1 |
paired related homeobox 1 |
647 |
0.82 |
chr18_55469415_55469689 | 0.78 |
ATP8B1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
775 |
0.71 |
chr7_1280480_1280631 | 0.78 |
UNCX |
UNC homeobox |
8012 |
0.22 |
chr10_73835799_73836159 | 0.78 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
12107 |
0.23 |
chr5_56497391_56497542 | 0.78 |
GPBP1 |
GC-rich promoter binding protein 1 |
12482 |
0.24 |
chr17_29816504_29816795 | 0.78 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
1523 |
0.31 |
chr2_219135450_219135615 | 0.77 |
PNKD |
paroxysmal nonkinesigenic dyskinesia |
324 |
0.61 |
chr7_657809_658035 | 0.77 |
AC147651.4 |
|
15100 |
0.17 |
chr17_3876088_3876269 | 0.76 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
8442 |
0.19 |
chr8_38324699_38325061 | 0.76 |
FGFR1 |
fibroblast growth factor receptor 1 |
345 |
0.86 |
chr14_73001912_73002081 | 0.76 |
RGS6 |
regulator of G-protein signaling 6 |
75619 |
0.12 |
chr7_1086241_1086392 | 0.76 |
GPR146 |
G protein-coupled receptor 146 |
2104 |
0.17 |
chr1_19261758_19261909 | 0.76 |
IFFO2 |
intermediate filament family orphan 2 |
20359 |
0.16 |
chr19_8639084_8639286 | 0.76 |
MYO1F |
myosin IF |
3137 |
0.16 |
chr19_8641468_8641709 | 0.75 |
MYO1F |
myosin IF |
734 |
0.53 |
chr2_8612472_8612957 | 0.75 |
AC011747.7 |
|
203182 |
0.03 |
chr19_42463079_42463289 | 0.75 |
RABAC1 |
Rab acceptor 1 (prenylated) |
118 |
0.95 |
chr2_109225621_109225839 | 0.75 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
2113 |
0.38 |
chr2_171508005_171508245 | 0.74 |
AC007277.3 |
|
7671 |
0.24 |
chr19_30164531_30164764 | 0.74 |
PLEKHF1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
6866 |
0.24 |
chr11_72331841_72332069 | 0.74 |
ENSG00000251919 |
. |
855 |
0.48 |
chr11_133798697_133798899 | 0.74 |
IGSF9B |
immunoglobulin superfamily, member 9B |
17389 |
0.18 |
chr1_24236042_24236237 | 0.73 |
RP11-4M23.3 |
|
2538 |
0.16 |
chr7_45016461_45016905 | 0.73 |
MYO1G |
myosin IG |
2014 |
0.23 |
chr4_7001264_7001415 | 0.73 |
TBC1D14 |
TBC1 domain family, member 14 |
429 |
0.69 |
chr3_47404358_47404541 | 0.73 |
RP11-708J19.1 |
|
18040 |
0.15 |
chr2_197037542_197037800 | 0.73 |
STK17B |
serine/threonine kinase 17b |
1372 |
0.45 |
chr11_73724256_73724416 | 0.73 |
UCP3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
3856 |
0.19 |
chr9_139437871_139438048 | 0.73 |
RP11-413M3.4 |
|
626 |
0.5 |
chr11_118764310_118764492 | 0.73 |
RP11-158I9.5 |
|
5950 |
0.1 |
chr9_92091076_92091227 | 0.73 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
3654 |
0.28 |
chr17_55676897_55677184 | 0.73 |
RP11-118E18.4 |
|
8733 |
0.2 |
chr2_98335568_98335943 | 0.72 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
5578 |
0.19 |
chr19_35942173_35942401 | 0.72 |
FFAR2 |
free fatty acid receptor 2 |
1670 |
0.25 |
chr14_22851143_22851294 | 0.72 |
ENSG00000251002 |
. |
50501 |
0.1 |
chr3_101798103_101798306 | 0.72 |
ZPLD1 |
zona pellucida-like domain containing 1 |
19884 |
0.27 |
chr8_100712615_100712912 | 0.72 |
ENSG00000243254 |
. |
86457 |
0.08 |
chr13_109064773_109065043 | 0.71 |
ENSG00000223177 |
. |
111229 |
0.07 |
chr3_32473425_32473576 | 0.71 |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
39969 |
0.16 |
chr14_91882380_91882531 | 0.71 |
CCDC88C |
coiled-coil domain containing 88C |
1235 |
0.55 |
chr1_31223327_31223571 | 0.71 |
LAPTM5 |
lysosomal protein transmembrane 5 |
7218 |
0.16 |
chr14_77590383_77590546 | 0.71 |
TMEM63C |
transmembrane protein 63C |
7553 |
0.15 |
chr3_145878177_145878434 | 0.71 |
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
474 |
0.85 |
chr16_68307404_68307696 | 0.71 |
SLC7A6 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 |
668 |
0.46 |
chr2_136809758_136810032 | 0.71 |
AC093391.2 |
|
39860 |
0.17 |
chr6_112311435_112311966 | 0.70 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
63575 |
0.11 |
chr3_43235608_43235867 | 0.70 |
ENSG00000222331 |
. |
16626 |
0.22 |
chr8_126658824_126659129 | 0.70 |
ENSG00000266452 |
. |
202169 |
0.03 |
chr5_149788138_149788399 | 0.70 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
4027 |
0.2 |
chr13_101262318_101262661 | 0.70 |
GGACT |
gamma-glutamylamine cyclotransferase |
20707 |
0.19 |
chr7_50250289_50250673 | 0.70 |
AC020743.2 |
|
68062 |
0.11 |
chr16_67679907_67680264 | 0.70 |
RLTPR |
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
935 |
0.38 |
chr2_30556139_30556290 | 0.70 |
ENSG00000221377 |
. |
99100 |
0.07 |
chr19_3053226_3053377 | 0.70 |
AC005944.2 |
|
393 |
0.77 |
chr1_226840322_226840473 | 0.70 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
6974 |
0.22 |
chr19_10664057_10664208 | 0.70 |
ENSG00000221410 |
. |
1334 |
0.2 |
chr20_43247301_43247452 | 0.70 |
Z97053.1 |
Uncharacterized protein |
750 |
0.57 |
chr12_56332773_56332924 | 0.69 |
DGKA |
diacylglycerol kinase, alpha 80kDa |
1911 |
0.17 |
chr16_31707620_31707947 | 0.69 |
CLUHP3 |
clustered mitochondria (cluA/CLU1) homolog pseudogene 3 |
6706 |
0.17 |
chr1_226912901_226913052 | 0.69 |
ITPKB |
inositol-trisphosphate 3-kinase B |
12183 |
0.22 |
chr3_46987856_46988201 | 0.69 |
CCDC12 |
coiled-coil domain containing 12 |
30242 |
0.12 |
chr11_35072442_35072670 | 0.69 |
PDHX |
pyruvate dehydrogenase complex, component X |
73225 |
0.08 |
chr1_101746005_101746240 | 0.68 |
RP4-575N6.5 |
|
37408 |
0.14 |
chr2_205812681_205812895 | 0.68 |
PARD3B |
par-3 family cell polarity regulator beta |
402065 |
0.01 |
chr6_91121876_91122034 | 0.68 |
ENSG00000252676 |
. |
34536 |
0.21 |
chr17_17660429_17660626 | 0.68 |
RAI1-AS1 |
RAI1 antisense RNA 1 |
13608 |
0.13 |
chr9_34983449_34984034 | 0.68 |
DNAJB5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
5897 |
0.15 |
chr7_37403219_37403780 | 0.68 |
ELMO1 |
engulfment and cell motility 1 |
10227 |
0.2 |
chr20_32371402_32371553 | 0.68 |
RP4-553F4.6 |
|
9356 |
0.15 |
chr2_231527868_231528072 | 0.68 |
CAB39 |
calcium binding protein 39 |
49590 |
0.13 |
chr7_100770227_100770378 | 0.68 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
68 |
0.95 |
chr5_1268781_1268932 | 0.68 |
TERT |
telomerase reverse transcriptase |
26248 |
0.14 |
chr1_25888128_25888408 | 0.68 |
LDLRAP1 |
low density lipoprotein receptor adaptor protein 1 |
18197 |
0.19 |
chr14_66316219_66316587 | 0.67 |
CTD-2014B16.3 |
Uncharacterized protein |
154838 |
0.04 |
chr17_30772177_30772396 | 0.67 |
PSMD11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
399 |
0.8 |
chr19_32836946_32837097 | 0.67 |
ZNF507 |
zinc finger protein 507 |
396 |
0.85 |
chr4_36311977_36312128 | 0.67 |
DTHD1 |
death domain containing 1 |
26408 |
0.2 |
chr21_43648899_43649521 | 0.67 |
ENSG00000223262 |
. |
7927 |
0.18 |
chr7_44751743_44751894 | 0.67 |
ZMIZ2 |
zinc finger, MIZ-type containing 2 |
36362 |
0.14 |
chr5_177641400_177641551 | 0.67 |
HNRNPAB |
heterogeneous nuclear ribonucleoprotein A/B |
9903 |
0.18 |
chr16_67269604_67269755 | 0.67 |
TMEM208 |
transmembrane protein 208 |
8608 |
0.07 |
chr17_61773789_61773940 | 0.67 |
LIMD2 |
LIM domain containing 2 |
2658 |
0.22 |
chr1_226870909_226871060 | 0.67 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
8216 |
0.21 |
chr16_79303009_79303465 | 0.67 |
ENSG00000222244 |
. |
4886 |
0.33 |
chr6_41997070_41997265 | 0.67 |
ENSG00000206875 |
. |
10915 |
0.15 |
chrX_128890428_128890790 | 0.66 |
XPNPEP2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
17611 |
0.18 |
chr7_30635049_30635380 | 0.66 |
ENSG00000196295 |
. |
789 |
0.45 |
chr19_8559254_8559405 | 0.66 |
PRAM1 |
PML-RARA regulated adaptor molecule 1 |
8166 |
0.12 |
chr13_52396330_52396557 | 0.66 |
RP11-327P2.5 |
|
18010 |
0.18 |
chr14_93124277_93124612 | 0.66 |
RIN3 |
Ras and Rab interactor 3 |
5598 |
0.29 |
chr22_37631085_37631236 | 0.66 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
9128 |
0.14 |
chr10_11215052_11215405 | 0.66 |
RP3-323N1.2 |
|
1889 |
0.38 |
chr2_12655320_12655605 | 0.66 |
ENSG00000207183 |
. |
103835 |
0.08 |
chr21_47970216_47970537 | 0.66 |
ENSG00000272283 |
. |
14667 |
0.17 |
chr2_69007339_69007580 | 0.65 |
ARHGAP25 |
Rho GTPase activating protein 25 |
5387 |
0.26 |
chr1_167620769_167621002 | 0.65 |
RP3-455J7.4 |
|
20974 |
0.18 |
chr12_46572416_46572589 | 0.65 |
SLC38A1 |
solute carrier family 38, member 1 |
88982 |
0.1 |
chr20_52369078_52369520 | 0.65 |
ENSG00000238468 |
. |
84002 |
0.09 |
chr3_151972127_151972302 | 0.65 |
MBNL1 |
muscleblind-like splicing regulator 1 |
13615 |
0.22 |
chr5_118668515_118668695 | 0.65 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
265 |
0.93 |
chr7_150372107_150372395 | 0.65 |
GIMAP2 |
GTPase, IMAP family member 2 |
10537 |
0.17 |
chr6_159138780_159139147 | 0.65 |
ENSG00000265558 |
. |
46822 |
0.12 |
chr1_110448427_110448592 | 0.65 |
CSF1 |
colony stimulating factor 1 (macrophage) |
4355 |
0.2 |
chr7_157664166_157664317 | 0.65 |
RP11-452C13.1 |
|
3011 |
0.31 |
chr2_30447134_30447325 | 0.65 |
LBH |
limb bud and heart development |
7168 |
0.23 |
chr21_44010697_44010940 | 0.65 |
AP001625.6 |
|
28774 |
0.14 |
chr14_100550956_100551196 | 0.65 |
CTD-2376I20.1 |
|
9861 |
0.14 |
chr3_46482772_46482982 | 0.64 |
LTF |
lactotransferrin |
22284 |
0.13 |
chr13_41538107_41538308 | 0.64 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
18211 |
0.18 |
chr14_75716729_75717032 | 0.64 |
RP11-293M10.2 |
|
9234 |
0.15 |
chr1_19398613_19398764 | 0.64 |
UBR4 |
ubiquitin protein ligase E3 component n-recognin 4 |
10046 |
0.2 |
chr18_22930641_22930889 | 0.64 |
ZNF521 |
zinc finger protein 521 |
392 |
0.91 |
chr11_118567796_118568096 | 0.64 |
ENSG00000207462 |
. |
5105 |
0.14 |
chr7_74596066_74596450 | 0.64 |
GTF2IRD2B |
GTF2I repeat domain containing 2B |
39354 |
0.17 |
chr1_202613330_202613596 | 0.64 |
SYT2 |
synaptotagmin II |
882 |
0.64 |
chr7_37872732_37872883 | 0.63 |
NME8 |
NME/NM23 family member 8 |
15392 |
0.25 |
chr6_24961536_24961712 | 0.63 |
FAM65B |
family with sequence similarity 65, member B |
25436 |
0.19 |
chr1_1140948_1141273 | 0.63 |
TNFRSF18 |
tumor necrosis factor receptor superfamily, member 18 |
50 |
0.93 |
chr11_1860873_1861176 | 0.63 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
97 |
0.93 |
chr9_77766797_77767137 | 0.63 |
ENSG00000200041 |
. |
29570 |
0.16 |
chr14_99689884_99690335 | 0.63 |
AL109767.1 |
|
39176 |
0.16 |
chr1_153330729_153330880 | 0.63 |
S100A9 |
S100 calcium binding protein A9 |
474 |
0.68 |
chr12_15116052_15116331 | 0.63 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
1529 |
0.36 |
chr9_92070617_92071327 | 0.63 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
104 |
0.98 |
chr6_42355284_42355440 | 0.62 |
ENSG00000221252 |
. |
24772 |
0.2 |
chr2_198167630_198167967 | 0.62 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
555 |
0.73 |
chr2_8977053_8977204 | 0.62 |
KIDINS220 |
kinase D-interacting substrate, 220kDa |
602 |
0.84 |
chr1_160680819_160681118 | 0.62 |
CD48 |
CD48 molecule |
625 |
0.69 |
chr9_92271430_92271581 | 0.62 |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
51552 |
0.18 |
chr9_96232614_96232765 | 0.62 |
FAM120AOS |
family with sequence similarity 120A opposite strand |
16815 |
0.14 |
chr14_91823061_91823237 | 0.62 |
ENSG00000265856 |
. |
23092 |
0.2 |
chr5_131336901_131337354 | 0.61 |
ACSL6 |
acyl-CoA synthetase long-chain family member 6 |
447 |
0.74 |
chr9_95474571_95474832 | 0.61 |
IPPK |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
42154 |
0.14 |
chr17_29820492_29820738 | 0.61 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
5489 |
0.15 |
chrX_9286819_9287136 | 0.61 |
TBL1X |
transducin (beta)-like 1X-linked |
144358 |
0.05 |
chr20_37632354_37632505 | 0.61 |
DHX35 |
DEAH (Asp-Glu-Ala-His) box polypeptide 35 |
18087 |
0.21 |
chr6_143866372_143866586 | 0.61 |
PHACTR2 |
phosphatase and actin regulator 2 |
8497 |
0.17 |
chr22_23165327_23165488 | 0.61 |
ENSG00000207836 |
. |
137 |
0.6 |
chr13_74630111_74630262 | 0.61 |
KLF12 |
Kruppel-like factor 12 |
61000 |
0.16 |
chr4_84133809_84134156 | 0.61 |
COQ2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
71936 |
0.1 |
chr20_30922259_30922738 | 0.61 |
ASXL1 |
additional sex combs like 1 (Drosophila) |
23657 |
0.15 |
chr20_61609635_61609803 | 0.61 |
SLC17A9 |
solute carrier family 17 (vesicular nucleotide transporter), member 9 |
25321 |
0.13 |
chr9_134595940_134596091 | 0.61 |
ENSG00000240853 |
. |
4839 |
0.23 |
chr3_37034061_37034212 | 0.61 |
EPM2AIP1 |
EPM2A (laforin) interacting protein 1 |
659 |
0.43 |
chr10_126326077_126326642 | 0.61 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
65835 |
0.11 |
chr12_125353884_125354097 | 0.60 |
SCARB1 |
scavenger receptor class B, member 1 |
5527 |
0.21 |
chr1_100862907_100863178 | 0.60 |
ENSG00000216067 |
. |
18711 |
0.19 |
chr9_132656304_132656600 | 0.60 |
FNBP1 |
formin binding protein 1 |
25137 |
0.14 |
chr16_3118727_3118954 | 0.60 |
ENSG00000252561 |
. |
684 |
0.37 |
chr14_71126040_71126306 | 0.60 |
TTC9 |
tetratricopeptide repeat domain 9 |
17669 |
0.2 |
chr2_97562196_97562433 | 0.60 |
FAM178B |
family with sequence similarity 178, member B |
1556 |
0.32 |
chr7_129260518_129260719 | 0.60 |
NRF1 |
nuclear respiratory factor 1 |
9021 |
0.24 |
chr17_79825208_79825359 | 0.60 |
RP11-498C9.3 |
|
314 |
0.7 |
chr5_175956210_175956448 | 0.60 |
RNF44 |
ring finger protein 44 |
1317 |
0.33 |
chr8_134074351_134074605 | 0.60 |
SLA |
Src-like-adaptor |
1875 |
0.43 |
chr3_71924513_71924711 | 0.60 |
ENSG00000239250 |
. |
48284 |
0.16 |
chr2_233941021_233941189 | 0.60 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
15916 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 0.7 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.3 | 1.0 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.3 | 1.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 2.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 1.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 1.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 1.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 1.0 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.2 | 0.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 1.5 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.2 | 0.5 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 1.0 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.5 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.2 | 0.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.2 | 0.7 | GO:0001743 | optic placode formation(GO:0001743) |
0.2 | 1.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 0.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 1.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.8 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 0.6 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.2 | 0.6 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.2 | 0.6 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 1.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 1.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.3 | GO:0002335 | mature B cell differentiation involved in immune response(GO:0002313) mature B cell differentiation(GO:0002335) |
0.2 | 0.9 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.2 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.2 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.2 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002460) |
0.2 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.5 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 0.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.2 | 0.8 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.3 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.2 | 0.8 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.2 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.2 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.6 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 1.0 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.4 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.4 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.4 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.1 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.4 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.3 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 1.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 3.8 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.4 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 1.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.4 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 1.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.5 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.8 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.2 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.6 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.9 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.2 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.1 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.5 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 2.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 1.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.8 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 2.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.9 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.8 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 0.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.2 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.4 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.2 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation(GO:0033083) |
0.1 | 0.2 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.2 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 1.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.1 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.4 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 1.4 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.6 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.3 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.1 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.2 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.1 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.1 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.4 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 4.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 1.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 1.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.3 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.3 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.6 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.2 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.4 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.4 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.6 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 3.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.2 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.1 | 0.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.1 | 2.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 1.2 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.2 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.6 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.1 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0043299 | leukocyte degranulation(GO:0043299) |
0.1 | 0.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.2 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.2 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 1.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.8 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.4 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.4 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 0.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 3.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.5 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.2 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.8 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 1.0 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.5 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.1 | GO:0014741 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.6 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.6 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.4 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.1 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.1 | 0.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.3 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.9 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.1 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 1.2 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.1 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.2 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 2.7 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.5 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 2.2 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.0 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.7 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.7 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.4 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 3.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.0 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.7 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.0 | 0.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.2 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.2 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 1.6 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.0 | 0.3 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 1.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.4 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0043092 | L-amino acid import(GO:0043092) |
0.0 | 0.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.1 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.4 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.0 | 0.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.2 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.0 | 0.1 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.0 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.1 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.9 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.4 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 1.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.3 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.4 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.5 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.2 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 3.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.3 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.0 | 0.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.0 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 2.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.3 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.5 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 1.3 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0072243 | metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 1.6 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.0 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.4 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 1.5 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.6 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.0 | 0.3 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.9 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:1903523 | negative regulation of heart contraction(GO:0045822) negative regulation of blood circulation(GO:1903523) |
0.0 | 0.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 1.0 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.0 | 0.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.6 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 0.2 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.6 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.0 | 0.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.2 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.0 | GO:0031623 | receptor internalization(GO:0031623) |
0.0 | 0.0 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.3 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 1.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.0 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.7 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.1 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.0 | 0.4 | GO:0015748 | organophosphate ester transport(GO:0015748) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 3.3 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.0 | 0.2 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.4 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.0 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.2 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.1 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.0 | 0.1 | GO:0048708 | astrocyte differentiation(GO:0048708) |
0.0 | 0.7 | GO:0050776 | regulation of immune response(GO:0050776) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 1.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.5 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.2 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.0 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.0 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.0 | 0.0 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway(GO:0002768) |
0.0 | 0.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.4 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.0 | 0.0 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 1.4 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.0 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.1 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.9 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.6 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.0 | 1.2 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.0 | 1.4 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.1 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 2.3 | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules(GO:0098742) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.5 | GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity(GO:0051090) |
0.0 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.1 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 1.4 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.0 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.0 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.7 | GO:0034248 | regulation of cellular amide metabolic process(GO:0034248) |
0.0 | 0.1 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) |
0.0 | 0.2 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 2.4 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.2 | GO:0009582 | detection of abiotic stimulus(GO:0009582) |
0.0 | 0.0 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.8 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.0 | 0.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.0 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.1 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0098930 | axonal transport(GO:0098930) |
0.0 | 0.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.2 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.8 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.3 | 1.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 1.3 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 1.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.5 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.9 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.8 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 1.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.1 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 1.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.8 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.1 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 2.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.7 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 2.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.2 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 2.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0098533 | cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.6 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 3.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
0.1 | 1.9 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 1.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.6 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 2.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.0 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 2.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.3 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.5 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 3.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.5 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.0 | GO:0030684 | preribosome(GO:0030684) small-subunit processome(GO:0032040) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 3.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.6 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 1.3 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 1.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 2.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 3.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.2 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.0 | 0.6 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 3.0 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 3.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 3.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 2.7 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 1.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.9 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.8 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 2.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.0 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 1.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 2.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 1.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 3.0 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 1.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 5.0 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 20.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 1.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 1.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 9.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 65.9 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.9 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 11.2 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.2 | GO:0005819 | spindle(GO:0005819) |
0.0 | 51.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0036464 | ribonucleoprotein granule(GO:0035770) cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.0 | 0.3 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 1.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 3.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 0.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 3.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 1.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.5 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.2 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.5 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 2.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.2 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.2 | GO:0004407 | histone deacetylase activity(GO:0004407) NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H3-K9 specific)(GO:0032129) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.0 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.5 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) cation:amino acid symporter activity(GO:0005416) |
0.1 | 1.9 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 3.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 1.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 2.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.6 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.1 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.1 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.6 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 5.3 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.4 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 1.3 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 2.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0045182 | translation repressor activity(GO:0030371) translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 1.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.0 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 5.8 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.9 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 1.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 1.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 1.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 1.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 8.7 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 1.8 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 2.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 2.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.4 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.0 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.6 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 1.1 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 1.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.6 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 5.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.8 | GO:0031267 | small GTPase binding(GO:0031267) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 8.1 | GO:0019001 | GTP binding(GO:0005525) guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 1.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 13.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 1.2 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.0 | 0.3 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.0 | 2.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 1.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 28.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.1 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.4 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 3.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.0 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.0 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.3 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 1.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.6 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.9 | GO:0019900 | kinase binding(GO:0019900) |
0.0 | 0.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 13.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 5.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 4.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 3.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.6 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 3.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 2.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 2.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 3.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 3.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.8 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 3.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.8 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 2.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 2.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 3.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 1.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 4.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 2.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 2.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 3.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 1.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 1.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 4.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 2.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |